About Careers Internship MedBlog Contact us

Cancer Incidence, Death Rate On the Decline in US: Report

by VR Sreeraman on November 26, 2008 at 12:17 PM
Font : A-A+

 Cancer Incidence, Death Rate On the Decline in US: Report

The rate at which new cancers are diagnosed and the death rate from the disease have both decreased in the United States for the first time in 10 years, according to a report published Tuesday by the National Cancer Institute.

"For the first time since the report was first issued in 1998, both incidence and death rates for all cancers combined are decreasing for both men and women, driven largely by declines in some of the most common types of cancer," said the Annual Report to the Nation on the Status of Cancer, which tracks trends in the illness from 1975-2005.


Although the cancer mortality rate has been declining since the report was first published 10 years ago, what researchers found noteworthy in this year's report was the fact that the cancer diagnosis rate also fell.

"The decline in both incidence and death rates for all cancers combined is due in large part to declines in the three most common cancers among men (lung, colon/rectum and prostate) and the two most common cancers among women (breast and colon/rectum) combined with a leveling off of lunch cancer death rates among women," the report said.

The rate at which new cancers were diagnosed fell by 0.8 percent per year from 1999-2005 for both men and women, while the death rate from cancer declined 1.8 percent from 2002 to 2005.

The continuing fall in mortality from cancer reflected "gains in prevention, early detection and treatment," said Otis Brawley, chief medical officer of the American Cancer Society (ACS).

But large differences still exist in cancer death rates by state and region, the report found.

It cited as an example the lung cancer death rate, which among men in California dropped more than twice as much as it did in many midwestern and southern states in 2005.

Among women, lung cancer death rates increased in 13 states and decreased in only three between 1996 and 2005, the report said, urging tougher tobacco control programs.

The 13 states where lung cancer death rates for women are on the rise have "higher percentages of adult female smokers, low excise taxes and local economies that are traditionally dependent on tobacco farming and production," it said.

"We can see that in areas of the country where smoking and tobacco use are entrenched in daily life, men and women continue to pay a price with higher incidence and death rates from many types of cancer, urging a greater commitment by officials to implementing tobacco control programs," said Betsy Kohler, head of the North American Association of Central Cancer Registries (NAACCR).

Cigarette smoking accounts for around 30 percent of all cancer deaths in the United States, and lung cancer for eight in 10 smoking-related cancer deaths, according to the US Surgeon General's report.

Cancers of the oral cavity, pharynx, larynx, esophagus, stomach, bladder, pancreas, liver, kidney and uterine cervix are also caused by smoking, as is a form of leukemia, the Surgeon General's report said.

The annual cancer report will be published on the Internet on Tuesday, and will appear in the December 2 edition of the Journal of the National Cancer Institute.

Source: AFP


Recommended Readings

Latest Cancer News

Combination Therapy may Benefit Leukemia Patients
The new study uncovers the efficacy of fixed-duration combination treatment in patients with high-risk leukemia.
 Myelofibrosis: New Drugs to Revolutionize Treatment
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
 Blood Vessels Can Kill Cancer Cells and Stop Breast Cancer Spread
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
 Weed Killer Agent Orange May Increase the Risk of Blood Cancer Among Veterans
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Two Years: Optimal Duration of Immunotherapy in Advanced Lung Cancer
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Cancer Incidence, Death Rate On the Decline in US: Report Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests